Literature DB >> 35181546

Diagnosis and Management of Pediatric Hypereosinophilic Syndrome.

Chen E Rosenberg1, Patricia C Fulkerson2, Kelli W Williams3.   

Abstract

Hypereosinophilic syndrome (HES) is a diverse group of disorders characterized by peripheral blood eosinophilia of 1.5 × 109/L (1,500/μL) or greater with evidence of end-organ damage attributable to eosinophilia and no other cause of the end-organ damage. The HES is rare, especially in children. This review aims to provide best practices in diagnosis and treatment of HES in children, including how to differentiate between primary and secondary causes of hypereosinophilia; how to distinguish the differences in clinical presentation, treatment, and prognosis of HES in children and adults; and how to identify key steps in the evaluation and management of HES in children.
Copyright © 2022 American Academy of Allergy, Asthma & Immunology. All rights reserved.

Entities:  

Keywords:  Children; Elevated eosinophils; Hypereosinophilia; Hypereosinophilic syndrome; Pediatric

Mesh:

Year:  2022        PMID: 35181546     DOI: 10.1016/j.jaip.2022.02.007

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  1 in total

1.  Case report: Application of non-VKA oral anticoagulants in patient of idiopathic hypereosinophilic syndrome with intracardiac thrombus.

Authors:  Man Zou; Geyan Liu; Yanhui Li
Journal:  Front Pharmacol       Date:  2022-09-19       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.